Evidence map›Paper›PMID 37308679›Full record

ArticleMolecular psychiatry2023

Distinct neural networks predict cocaine versus cannabis treatment outcomes.

Sarah D Lichenstein, Robert Kohler, Fengdan Ye, Marc N Potenza, Brian Kiluk, Sarah W Yip

3 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in Molecular psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00350649 phase2completednot on this map

Maximizing the Efficacy of Cognitive Behavior Therapy and Contingency Management

TypeinterventionalSponsorYale UniversityRan2004 to 2010Enrolled205ConditionsMarijuana DependenceArmsStandard CBT, CBT+CM/adherence, CM/abstinence, CM/abstinence+CBT
NCT01406899 phase1completednot on this map

Computer-Assisted Cognitive Behavior Therapy for Veterans With Substance Use Disorder

TypeinterventionalSponsorVA Connecticut Healthcare SystemRan2010 to 2013Enrolled80ConditionsSubstance-Related DisordersArmsComputer Based Treatment
NCT01442597 phase1 / phase2completednot on this map

Computer Based Training in Cognitive Behavioral Therapy Web-based

TypeinterventionalSponsorYale UniversityRan2012 to 2018Enrolled164ConditionsSubstance AbuseArmsStandard Treatment As Usual (TAU), Individual clinician-provided CBT, CBT4CBT
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Connectome-based encoding of subjective drug responses to acute oral methamphetamine.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sarah D LichensteinDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA. sarah.lichenstein@yale.edu.ORCID 0000-0002-2978-991X
Robert KohlerDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Fengdan YeStripe, San Francisco, CA, USA.
Marc N PotenzaDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0002-6323-1354
Brian KilukDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Sarah W YipDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0003-2293-2864
Yale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
TSF to enhance treatment of cocaine dependenceP50DA009241 · NIDA · YALE UNIVERSITY · PI CARROLL, KATHLEEN M. · 1994 to 2018
$40.5M
Research Training Fellowship in Substance use and Addiction (RTFSA)T32DA007238 · NIDA · YALE UNIVERSITY · PI BRIAN D. KILUK, ISMENE L. PETRAKIS · 1988 to 2026
$5.7M
Neural mechanisms of CBT in cocaine dependence (Gender Differences Supplement)R01DA035058 · NIDA · YALE UNIVERSITY · PI CARROLL, KATHLEEN M., POTENZA, MARC N · 2013 to 2016
$2.3M
Development of the Stimulant Use Disorder Severity ScaleU01DA051639 · NIDA · YALE UNIVERSITY · PI KILUK, BRIAN D. · 2020 to 2023
$1.8M
fMRI of CBT and CM for Cocaine DependenceR01DA020908 · NIDA · YALE UNIVERSITY · PI POTENZA, MARC N · 2005 to 2009
$1.7M
Connectome-based prediction and neurodevelopmental trajectories of alcohol phenotypes across developmentR01AA027553 · NIAAA · YALE UNIVERSITY · PI SCHEINOST, DUSTIN, YIP, SARAH · 2019 to 2022
$1.7M
fMRI of Craving in Addictions: Gender DifferencesR01DA019039 · NIDA · YALE UNIVERSITY · PI POTENZA, MARC N · 2005 to 2009
$1.6M
Connectome-based neuromarkers of problem cannabis useK08DA051667 · NIDA · YALE UNIVERSITY · PI LICHENSTEIN, SARAH D. · 2020 to 2024
$959k
Functional networks related to cocaine dependence and its treatment and relapseR01DA039136 · NIDA · YALE UNIVERSITY · PI POTENZA, MARC N · 2016 to 2018
$754k
Integrating Cognitive Neuroscience Toward Understanding of Mechanisms of CBT for Alcohol Use DisordersK02AA027300 · NIAAA · YALE UNIVERSITY · PI KILUK, BRIAN D. · 2019 to 2023
$719k
NCATS NIH HHS UL1 TR001863NIAAA NIH HHS K02 AA027300NIAAA NIH HHS R01 AA027553NIDA NIH HHS K08 DA051667NIDA NIH HHS P50 DA009241NIDA NIH HHS R01 DA019039NIDA NIH HHS R01 DA020908NIDA NIH HHS R01 DA035058NIDA NIH HHS R01 DA039136NIDA NIH HHS T32 DA007238NIDA NIH HHS U01 DA051639
6 · The paper itself

Abstract

Treatment outcomes for individuals with substance use disorders (SUDs) are variable and more individualized approaches may be needed. Cross-validated, machine-learning methods are well-suited for probing neural mechanisms of treatment outcomes. Our prior work applied one such approach, connectome-based predictive modeling (CPM), to identify dissociable and substance-specific neural networks of cocaine and opioid abstinence. In Study 1, we aimed to replicate and extend prior work by testing the predictive ability of the cocaine network in an independent sample of 43 participants from a trial of cognitive-behavioral therapy for SUD, and evaluating its ability to predict cannabis abstinence. In Study 2, CPM was applied to identify an independent cannabis abstinence network. Additional participants were identified for a combined sample of 33 with cannabis-use disorder. Participants underwent fMRI scanning before and after treatment. Additional samples of 53 individuals with co-occurring cocaine and opioid-use disorders and 38 comparison subjects were used to assess substance specificity and network strength relative to participants without SUDs. Results demonstrated a second external replication of the cocaine network predicting future cocaine abstinence, however it did not generalize to cannabis abstinence. An independent CPM identified a novel cannabis abstinence network, which was (i) anatomically distinct from the cocaine network, (ii) specific for predicting cannabis abstinence, and for which (iii) network strength was significantly stronger in treatment responders relative to control particpants. Results provide further evidence for substance specificity of neural predictors of abstinence and provide insight into neural mechanisms of successful cannabis treatment, thereby identifying novel treatment targets. Clinical trials registation: "Computer-based training in cognitive-behavioral therapy web-based (Man VS Machine)", registration number: NCT01442597 . "Maximizing the Efficacy of Cognitive Behavior Therapy and Contingency Management", registration number: NCT00350649 . "Computer-Based Training in Cognitive Behavior Therapy (CBT4CBT)", registration number: NCT01406899 .

Indexed as

CannabisCocaineCocaine-Related DisordersCognitive Behavioral TherapyOpioid-Related DisordersSubstance-Related DisordersHumansMaleTreatment OutcomeCocaine

Identifiers

PMID37308679
PMCPMC10713861
OpenAlexW4380324522

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.